![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » COMBIMATRIX MOLECULAR DIAGNOSTICS TO OFFER FIRST COMMERCIAL GENETIC TEST FROM ITS CLIA CERTIFIED LABORATORY
COMBIMATRIX MOLECULAR DIAGNOSTICS TO OFFER FIRST COMMERCIAL GENETIC TEST FROM ITS CLIA CERTIFIED LABORATORY
June 27, 2006
Acacia Research Corporation announced today that its CombiMatrix group's subsidiary, CombiMatrix Molecular Diagnostics (CMDX) is planning to commercially launch its first molecular diagnostic service offering in August, 2006.
Business
Wire
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct